| Jennifer Melanie Heibig, DO | |
|
1200 S Cedar Crest Blvd, Allentown, PA 18103-6202 | |
| (610) 402-5100 | |
| Not Available |
| Full Name | Jennifer Melanie Heibig |
|---|---|
| Gender | Female |
| Speciality | Student In An Organized Health Care Education/training Program |
| Location | 1200 S Cedar Crest Blvd, Allentown, Pennsylvania |
| Accepts Medicare Assignments | Does not participate in Medicare Program. She may not accept medicare assignment. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1063094803 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 207V00000X | Obstetrics & Gynecology | OT020564 (Pennsylvania) | Secondary |
| 390200000X | Student In An Organized Health Care Education/training Program | (* (Not Available)) | Primary |
| Mailing Address | Practice Location Address |
|---|---|
| Jennifer Melanie Heibig, DO 1200 S Cedar Crest Blvd, Allentown, PA 18103-6202 Ph: (610) 402-5100 | Jennifer Melanie Heibig, DO 1200 S Cedar Crest Blvd, Allentown, PA 18103-6202 Ph: (610) 402-5100 |
News Archive
The Washington Post reports that the question of how and if some immigrants will have access to care under health care reform remains one of the sticking points between the chambers as the Congressional debate unfolds.
Cardio3 BioSciences, a leading Belgian biotechnology company specialising in cell-based therapies for the treatment of cardiovascular diseases, announced today promising results in a pre-clinical study of its proprietary C-Cath(R) catheter which is under development to administer a range of bio-therapeutics to the heart. C-Cath is designed to take into account organ tissue structure and properties to maximize patients' safety, improve performance and increase user confidence during the injection procedure.
Scientists at the research Institute MIRA at the University of Twente have been working for some time on a new technique to detect breast cancer. The technique based on the physical principle of photoacoustics, has been christened PAMmography. It uses short bursts of light that cause ultrasonic waves to be generated in places with high density of blood vessels, such as in the vicinity of malignant tumours.
Corgenix Medical Corporation, a worldwide developer and marketer of diagnostic test kits, has announced the availability of its new automation friendly anti-phospholipid assay format.
Virginia Tech is participating in a new, landmark $30 million national effort sponsored by the National Collegiate Athletic Association and the U.S. Department of Defense to combat concussions among college athletes and active service military personnel.
› Verified 2 days ago